Валюты / CDNA
CDNA: CareDx Inc
13.66
USD
0.55
(4.20%)
Курс CDNA за сегодня изменился на 4.20%. При этом минимальная цена на торгах достигала 13.06, а максимальная — 13.76.
Следите за динамикой CareDx Inc. Котировки в реальном времени помогут быстро реагировать на изменения рынка. Переключаясь между различными таймфреймами, можно отслеживать тенденции и динамику курса по минутам, часам, дням, неделям и месяцам. Используйте эту информацию для прогнозирования изменений на рынке и принятия взвешенных торговых решений.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
Новости CDNA
- The Genomic Data Deluge: From Sequencing To Actionable Insights
- What's Going On With CareDx Stock Tuesday? - CareDx (NASDAQ:CDNA)
- William Blair initiates coverage on CareDx stock with Market Perform rating
- Do Options Traders Know Something About CareDx Stock We Don't?
- The Play On CareDx (NASDAQ:CDNA)
- CareDx stock price target lowered to $22 at BTIG on Medicare reimbursement concerns
- CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges
- CareDx secretary Novack sells $34,380 in shares
- Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings
- CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
- AlloSure kidney transplant test shows strong predictive value for rejection
- CareDx launches AI-driven AlloSure Plus integrated with EPIC Aura
- CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
- Medicare draft policy continues coverage for transplant testing
- Abbott, Eli Lilly Lead Thursday’s Market Cap Stock Movers
- Oracle, Abbott lead Thursday’s market cap stock movers
- Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings - GameSquare Holdings (NASDAQ:GAME), CareDx (NASDAQ:CDNA)
- Caredx Inc stock hits 52-week low at 14.07 USD
- CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance
- Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA)
- CareDx Stock : Transplant Diagnostics Leader; Challenges Will Increase (CDNA)
- CareDx at Goldman Sachs Conference: Strategic Growth and Expansion
- Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
- CareDx at Jefferies Global Healthcare: Strategic Growth and Market Focus
Дневной диапазон
13.06
13.76
Годовой диапазон
10.96
32.97
- Предыдущее закрытие
- 13.11
- Open
- 13.17
- Bid
- 13.66
- Ask
- 13.96
- Low
- 13.06
- High
- 13.76
- Объем
- 4.028 K
- Дневное изменение
- 4.20%
- Месячное изменение
- 12.99%
- 6-месячное изменение
- -37.60%
- Годовое изменение
- -54.86%
31 августа, воскресенье